Efficacy and Safety Profile of Different Schedules of Adjuvant Trastuzumab Therapy among Patients with HER2-Positive Breast Cancer: Real-World Experience from a Tertiary Cancer Center in South India

• Nandini Devi Rajan,
• Abhilash Menon,
• Praveen Kumar Shenoy,
• Manuprasad Avaronnan,
• Sherin Shahana,
• Bindu Therayangalath

Affiliations

Nandini Devi Rajan

Department of Medical Oncology, Malabar Cancer Centre, Moozhikkara (PO), Thalassery, Kannur District, Kerala, India

Abhilash Menon

Department of Medical Oncology, Malabar Cancer Centre, Moozhikkara (PO), Thalassery, Kannur District, Kerala, India

Praveen Kumar Shenoy

ORCiD

Department of Medical Oncology, Malabar Cancer Centre, Moozhikkara (PO), Thalassery, Kannur District, Kerala, India

Manuprasad Avaronnan

Department of Medical Oncology, Aster MIMS, Kannur, Kerala, India

Sherin Shahana

Department of Medical Oncology, Malabar Cancer Centre, Moozhikkara (PO), Thalassery, Kannur District, Kerala, India

Bindu Therayangalath

ORCiD

Department of Cancer Registry and Biostatistics, Malabar Cancer Centre, Moozhikkara (PO), Thalassery, Kannur District, Kerala, India